Replies to post #201432 on Biotech Values

[DewDiligence]

CHRS -7% on sale of 4.03M* shares @$18.00—an 8% discount to Friday’s close:

http://finance.yahoo.com/news/coherus-prices-public-offering-common-132008941.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

(MNTA/ABBV)—CHRS seeks IPRs on four more Humira patents:

http://www.bigmoleculewatch.com/2017/01/31/coherus-files-four-petitions-for-inter-partes-review-of-abbvies-adalimumab-related-patent/

See #msg-126385726 and #msg-118781959 for related info.